Chart Events
Performance Outlook
| Previous Close | 311.70 |
| Open | 310.40 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 305.10 - 312.60 |
| 52 Week Range | 196.00 - 321.40 |
| Volume | 417,372 |
| Avg. Volume | 412,257 |
| Market Cap | 171.993B |
| Beta (5Y Monthly) | 0.42 |
| PE Ratio (TTM) | 48.45 |
| EPS (TTM) | 6.34 |
| Earnings Date | Feb 12, 2021 |
| Forward Dividend & Yield | 4.00 (1.28%) |
| Ex-Dividend Date | Apr 27, 2021 |
| 1y Target Est | 205.31 |
Fair Value
Related Research
- Barrons.com
L’Oréal Stock Boosted By E-Commerce and China Earnings. Analysts Think There’s More to Come.
The cosmetics giant posted results on Friday showing that sales accelerated in the fourth quarter of the year.
- Financial Times
L’Oréal predicts 1920s-style boom for beauty
L’Oréal, the world’s biggest cosmetics maker, envisions a boom for beauty once the Covid-19 pandemic subsides similar to the roaring 1920s that followed the global influenza pandemic of 1918. “This will be the fiesta of make-up and fragrances,” predicted chief executive Jean-Paul Agon at an investor conference on annual results on Friday. Both trends helped offset the damage wrought by the coronavirus pandemic last year, allowing L’Oréal to limit the profit hit from store and salon closures.
- Reuters
L'Oreal sees post-pandemic 'roaring 20s' driving cosmetics rebound
L'Oreal, the world's biggest cosmetics group, forecast a strong rebound in makeup sales when the COVID-19 pandemic gives way to a "roaring 20s" when people get dressed up and go out again to socialise. Shares in L'Oreal, owner of brands such as Maybelline, Lancome and Garnier, rose on Friday after the group reported higher than expected fourth-quarter sales growth, broadly outperforming a cosmetics market hit hard by the pandemic. L'Oreal CEO and Chairman Jean-Paul Agon said sales would accelerate sharply as COVID-19 vaccines are distributed and levels of infection subside.
